Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants

Ilaria Badagnani, Richard A. Castro, Travis R. Taylor, Claire M. Brett, Conrad C. Huang, Douglas Stryke, Michiko Kawamoto, Susan J. Johns, Thomas E. Ferrin, Elaine J. Carlson, Esteban G. Burchard and Kathleen M. Giacomini
Journal of Pharmacology and Experimental Therapeutics August 2006, 318 (2) 521-529; DOI: https://doi.org/10.1124/jpet.106.104364
Ilaria Badagnani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Castro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Travis R. Taylor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire M. Brett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Conrad C. Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Stryke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiko Kawamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan J. Johns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Ferrin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine J. Carlson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esteban G. Burchard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen M. Giacomini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Methotrexate (MTX) is used in patients with malignant and autoimmune diseases. This drug is primarily excreted unchanged in the urine, and its net excretion occurs via active secretory and reabsorptive processes. We characterized the interaction of MTX with human organic-anion transporting polypeptide transporter (OATP) 1A2, which is expressed in tissues important for MTX disposition and toxicity, such as the intestine, kidney, liver, and endothelial cells of the blood-brain barrier. In Xenopus laevis oocytes expressing OATP1A2, the uptake of the model substrate, estrone-3-sulfate (ES), was enhanced 30-fold compared with uninjected oocytes. MTX uptake in oocytes expressing OATP1A2 was saturable (Km = 457 ± 118 μM; Vmax = 17.5 ± 4.9 pmol/oocyte/60 min) and sensitive to extracellular pH. That is, acidic pHs stimulated MTX uptake by as much as 7-fold. Seven novel protein-altering variants were identified in 270 ethnically diverse DNA samples. Four protein-altering variants in OATP1A2 exhibited altered transport of ES and/or MTX. The common variant, protein reference sequence (p.) Ile13Thr, was hyperfunctional for ES and MTX and showed a 2-fold increase in the Vmax for ES. The common variant, p. Glu172Asp, exhibited reduced maximal transport capacity for ES and MTX. p. Arg168Cys was hypofunctional, and p. Asn277DEL was nonfunctional. Because of its expression on the apical membrane of the distal tubule and in tissues relevant to MTX disposition and toxicity, these findings suggest that OATP1A2 may play a role in active tubular reabsorption of MTX and in MTX-induced toxicities. Furthermore, genetic variation in OATP1A2 may contribute to variation in MTX disposition and response.

Footnotes

  • This work was supported by the National Institutes of Health Grants GM61390 and GM36780 and by the General Clinical Research Center at San Francisco General Hospital, funded by the National Center for Research Resources, National Institutes of Health (Grant MO1-RR00083-42). I.B. was supported in part by a National Science Foundation Graduate Research Fellowship.

  • Data in this manuscript were deposited in the Pharmacogenetics and Pharmacogenomics Knowledgebase (www.pharmgkb.org). Some parts of this study were presented as an abstract; Interaction of methotrexate with SLCO1A2 (OATP-A) and its 12 protein-altering variants: clinical implications for delayed excretion and nephrotoxicity; International Society for the Study of Xenobiotics Annual Meeting; 2005 October 23-27; Maui, HI. International Society for the Study of Xenobiotics, Washington, DC.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.106.104364.

  • ABBREVIATIONS: MTX, methotrexate; 7-OH-MTX, 7-hydroxymethotrexate; SLC, solute carrier; OATP, organic-anion transporting polypeptide; ES, estrone-3-sulfate; p., protein reference sequence; HEK293, human embryonic kidney cell line; cRNA, complementary RNA; FCCP, carbonylcyanide p-trifluoromethoxyphenyl hydrazone; ANOVA, analysis of variance; c., coding DNA reference sequence; TMD, transmembrane domain.

    • Received March 10, 2006.
    • Accepted May 11, 2006.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 377 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 377, Issue 2
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants

Ilaria Badagnani, Richard A. Castro, Travis R. Taylor, Claire M. Brett, Conrad C. Huang, Douglas Stryke, Michiko Kawamoto, Susan J. Johns, Thomas E. Ferrin, Elaine J. Carlson, Esteban G. Burchard and Kathleen M. Giacomini
Journal of Pharmacology and Experimental Therapeutics August 1, 2006, 318 (2) 521-529; DOI: https://doi.org/10.1124/jpet.106.104364

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCELLULAR AND MOLECULAR

Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants

Ilaria Badagnani, Richard A. Castro, Travis R. Taylor, Claire M. Brett, Conrad C. Huang, Douglas Stryke, Michiko Kawamoto, Susan J. Johns, Thomas E. Ferrin, Elaine J. Carlson, Esteban G. Burchard and Kathleen M. Giacomini
Journal of Pharmacology and Experimental Therapeutics August 1, 2006, 318 (2) 521-529; DOI: https://doi.org/10.1124/jpet.106.104364
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PARPi with vitamin C, decitabine or azacitidine for APL.
  • Circ-KRT6C/miR-485-3p/PDL1 axis in colorectal cancer.
  • Zebrafish Gstp1 Drug Response
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics